Cardiology is the branch of medicine that deals with the study, diagnosis and treatment of acquired of congenital cardiovascular diseases, which are the leading cause of death and morbidity in the western world. In addition to treating cardiovascular diseases, heart failure and heart rhythm abnormalities, cardiologists work on the prevention of cardiovascular diseases.
Cardiometabolic diseases are conditions affecting the heart or blood vessels; they represent the leading cause of death worldwide.
Over the last two decades the interest in omega-3 polyunsaturated fatty acids (PUFAs) has grown, thanks to their antidyslipidemic, anti-inflammatory, antiarrhythmic and antithrombotic properties. When not sufficiently provided with the diet, omega-3 obtained by esterification of triglycerides extracted from fish oil can be assumed alternatively as drugs. IBSA products contain omega -3 fatty acids (EPA/DHA) which have been certified as sustainably sourced by the NGO Friends of the Sea and have obtained the IFOS Five Star Certification for their purity, freshness and concentration. IBSA’s omega-3 are enclosed in a soft gelatine capsule that preserves their integrity and stability over time.
Recently in the cardiometabolic area IBSA has also developed two nutraceutical formulations containing monacolin k and other components that help maintaining the normal cholesterol levels in the blood.